Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Lung Cancer

  Free Subscription


13.03.2017

2 Ann Thorac Surg
1 Br J Cancer
1 Cancer
1 Cancer Chemother Pharmacol
1 Cancer Epidemiol Biomarkers Prev
1 Cancer Lett
3 Cancer Sci
1 Eur Respir J
3 Int J Oncol
2 Int J Radiat Oncol Biol Phys
1 J Cancer Res Clin Oncol
1 J Nucl Med
2 J Thorac Cardiovasc Surg
3 J Thorac Oncol
2 Lancet HIV
2 N Engl J Med
20 Oncol Rep
2 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Thorac Surg

  1. BARTA JA, Henschke CI, Flores RM, Yip R, et al
    Lung Cancer Diagnosis by Fine Needle Aspiration Is Associated With Reduction in Resection of Nonmalignant Lung Nodules.
    Ann Thorac Surg. 2017 Mar 5. pii: S0003-4975(16)31776.
    PubMed     Text format     Abstract available

  2. WAKEAM E, Giuliani M, Leighl NB, Finlayson SR, et al
    Indications for Adjuvant Mediastinal Radiotherapy in Surgically Resected Small Cell Lung Cancer.
    Ann Thorac Surg. 2017 Mar 3. pii: S0003-4975(16)31758.
    PubMed     Text format     Abstract available


    Br J Cancer

  3. HOLDENRIEDER S, Wehnl B, Hettwer K, Simon K, et al
    Carcinoembryonic antigen and cytokeratin-19 fragments for assessment of therapy response in non-small cell lung cancer: a systematic review and meta-analysis.
    Br J Cancer. 2017 Mar 9. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available


    Cancer

  4. KEATING JJ, Runge JJ, Singhal S, Nims S, et al
    Intraoperative near-infrared fluorescence imaging targeting folate receptors identifies lung cancer in a large-animal model.
    Cancer. 2017;123:1051-1060.
    PubMed     Text format     Abstract available


    Cancer Chemother Pharmacol

  5. KASHIWABARA K, Semba H, Fujii S, Tsumura S, et al
    Outcome in advanced non-small cell lung cancer patients with successful rechallenge after recovery from epidermal growth factor receptor tyrosine kinase inhibitor-induced interstitial lung disease.
    Cancer Chemother Pharmacol. 2017 Mar 3. doi: 10.1007/s00280-017-3261.
    PubMed     Text format     Abstract available


    Cancer Epidemiol Biomarkers Prev

  6. YU D, Takata Y, Smith-Warner SA, Blot W, et al
    Prediagnostic Calcium Intake and Lung Cancer Survival: A Pooled Analysis of 12 Cohort Studies.
    Cancer Epidemiol Biomarkers Prev. 2017 Mar 6. pii: cebp.0863.2016.
    PubMed     Text format     Abstract available


    Cancer Lett

  7. LI K, Mo C, Gong D, Chen Y, et al
    DDX17 nucleocytoplasmic shuttling promotes acquired gefitinib resistance in non-small cell lung cancer cells via activation of beta-catenin.
    Cancer Lett. 2017 Mar 1. pii: S0304-3835(17)30146.
    PubMed     Text format     Abstract available


    Cancer Sci

  8. HARADA A, Uchino J, Harada T, Nakagaki N, et al
    Vascular endothelial growth factor promoter-based conditionally replicative adenoviruses effectively suppress growth of malignant pleural mesothelioma.
    Cancer Sci. 2017;108:116-123.
    PubMed     Text format     Abstract available

  9. HIDA T, Nishio M, Nogami N, Ohe Y, et al
    Efficacy and safety of nivolumab in Japanese patients with advanced or recurrent squamous non-small cell lung cancer.
    Cancer Sci. 2017 Mar 7. doi: 10.1111/cas.13225.
    PubMed     Text format     Abstract available

  10. IKEMURA S, Aramaki N, Fujii S, Kirita K, et al
    Changes in the tumor microenvironment during lymphatic metastasis of lung squamous cell carcinoma.
    Cancer Sci. 2017;108:136-142.
    PubMed     Text format     Abstract available


    Eur Respir J

  11. ZUGAZAGOITIA J, Molina-Pinelo S, Lopez-Rios F, Paz-Ares L, et al
    Biological therapies in nonsmall cell lung cancer.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


    Int J Oncol

  12. YANG X, Han M, Han H, Wang B, et al
    Silencing Snail suppresses tumor cell proliferation and invasion by reversing epithelial-to-mesenchymal transition and arresting G2/M phase in non-small cell lung cancer.
    Int J Oncol. 2017 Feb 21. doi: 10.3892/ijo.2017.3888.
    PubMed     Text format     Abstract available

  13. YANG X, Tietje AH, Yu X, Wei Y, et al
    Mouse interleukin-12/FasTI: A novel bi-functional fusion protein for cancer immuno/gene therapy.
    Int J Oncol. 2016;48:2381-6.
    PubMed     Text format     Abstract available

  14. SRINUAL S, Chanvorachote P, Pongrakhananon V
    Suppression of cancer stem-like phenotypes in NCI-H460 lung cancer cells by vanillin through an Akt-dependent pathway.
    Int J Oncol. 2017 Feb 17. doi: 10.3892/ijo.2017.3879.
    PubMed     Text format     Abstract available


    Int J Radiat Oncol Biol Phys

  15. BROOKS ED, Sun B, Zhao L, Komaki R, et al
    Stereotactic Ablative Radiation Therapy is Highly Safe and Effective for Elderly Patients With Early-stage Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016 Dec 21. pii: S0360-3016(16)33596.
    PubMed     Text format     Abstract available

  16. GIULIANI M, Hope A, Guckenberger M, Mantel F, et al
    Stereotactic Body Radiation Therapy in Octo- and Nonagenarians for the Treatment of Early-Stage Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2017 Jan 9. pii: S0360-3016(17)30023.
    PubMed     Text format     Abstract available


    J Cancer Res Clin Oncol

  17. OLEKSIEWICZ U, Liloglou T, Tasopoulou KM, Daskoulidou N, et al
    COL1A1, PRPF40A, and UCP2 correlate with hypoxia markers in non-small cell lung cancer.
    J Cancer Res Clin Oncol. 2017 Mar 3. doi: 10.1007/s00432-017-2381.
    PubMed     Text format     Abstract available


    J Nucl Med

  18. VERA P, Thureau S, Chaumet-Riffaud P, Modzelewski R, et al
    Phase II study of a radiotherapy total dose increase in hypoxic lesions identified by F-miso PET/CT in patients with non-small cell lung carcinoma [RTEP5 study].
    J Nucl Med. 2017 Mar 2. pii: jnumed.116.188367. doi: 10.2967/jnumed.116.188367.
    PubMed     Text format     Abstract available


    J Thorac Cardiovasc Surg

  19. BURT BM
    Clarity and clairvoyance: Review and prediction of management guidelines for early stage lung cancer.
    J Thorac Cardiovasc Surg. 2017 Feb 8. pii: S0022-5223(17)30170.
    PubMed     Text format    

  20. HACHEY KJ, Digesu CS, Armstrong KW, Gilmore DM, et al
    A novel technique for tumor localization and targeted lymphatic mapping in early-stage lung cancer.
    J Thorac Cardiovasc Surg. 2017 Feb 10. pii: S0022-5223(17)30190.
    PubMed     Text format     Abstract available


    J Thorac Oncol

  21. SUN B, Brooks ED, Komaki R, Liao Z, et al
    Long-Term Outcomes of Salvage Stereotactic Ablation Radiotherapy for Isolated Lung Recurrence of Non-Small-Cell Lung Cancer: A Phase II Clinical Trial.
    J Thorac Oncol. 2017 Mar 1. pii: S1556-0864(17)30129.
    PubMed     Text format     Abstract available

  22. HATTORI A, Matsunaga T, Hayashi T, Takamochi K, et al
    Prognostic Impact of the Findings on Thin-Section Computed Tomography in Patients with Subcentimeter Non-Small Cell Lung Cancer.
    J Thorac Oncol. 2017 Feb 28. pii: S1556-0864(17)30126.
    PubMed     Text format     Abstract available

  23. YORK E, Varella-Garcia M, Bang TJ, Aisner DL, et al
    Tolerable and effective combination of full dose crizotinib and osimertinib targeting MET amplification sequentially emerging after T790M positivity in EGFR mutant non-small cell lung cancer.
    J Thorac Oncol. 2017 Mar 5. pii: S1556-0864(17)30167.
    PubMed     Text format    


    Lancet HIV

  24. CLIFFORD GM, Lise M, Franceschi S, Scherrer AU, et al
    CD4/CD8 ratio and lung cancer risk.
    Lancet HIV. 2017;4:e103.
    PubMed     Text format    

  25. SIGEL K, Dubrow R
    CD4/CD8 ratio and lung cancer risk - Authors' reply.
    Lancet HIV. 2017;4:e103-e104.
    PubMed     Text format    


    N Engl J Med

  26. SORSCHER S
    Pembrolizumab in Non-Small-Cell Lung Cancer.
    N Engl J Med. 2017;376:996-7.
    PubMed     Text format    


  27. Pembrolizumab in Non-Small-Cell Lung Cancer.
    N Engl J Med. 2017;376:997.
    PubMed     Text format    


    Oncol Rep

  28. WANG J, Weng Y, Zhang M, Li Y, et al
    BMP9 inhibits the growth and migration of lung adenocarcinoma A549 cells in a bone marrow stromal cellderived microenvironment through the MAPK/ERK and NF-kappaB pathways.
    Oncol Rep. 2016;36:410-8.
    PubMed     Text format     Abstract available

  29. WU Y, Yu DD, Hu Y, Yan D, et al
    Genome-wide profiling of long non-coding RNA expression patterns in the EGFR-TKI resistance of lung adenocarcinoma by microarray.
    Oncol Rep. 2016;35:3371-86.
    PubMed     Text format     Abstract available

  30. NAMBU J, Kobayashi T, Hashimoto M, Tashiro H, et al
    h-prune affects anaplastic thyroid cancer invasion and metastasis.
    Oncol Rep. 2016;35:3445-52.
    PubMed     Text format     Abstract available

  31. DUAN Q, Pang C, Chang N, Zhang J, et al
    Overexpression of PAD4 suppresses drug resistance of NSCLC cell lines to gefitinib through inhibiting Elk1-mediated epithelial-mesenchymal transition.
    Oncol Rep. 2016;36:551-8.
    PubMed     Text format     Abstract available

  32. WANG Z, Tang F, Hu P, Wang Y, et al
    HDAC6 promotes cell proliferation and confers resistance to gefitinib in lung adenocarcinoma.
    Oncol Rep. 2016;36:589-97.
    PubMed     Text format     Abstract available

  33. WU HJ, Wu HB, Zhao YQ, Chen LJ, et al
    Bergamottin isolated from Citrus bergamia exerts in vitro and in vivo antitumor activity in lung adenocarcinoma through the induction of apoptosis, cell cycle arrest, mitochondrial membrane potential loss and inhibition of cell migration and invasion.
    Oncol Rep. 2016;36:324-32.
    PubMed     Text format     Abstract available

  34. BAO Z, Lu G, Cui D, Yao Y, et al
    IL-17A-producing T cells are associated with the progression of lung adenocarcinoma.
    Oncol Rep. 2016;36:641-50.
    PubMed     Text format     Abstract available

  35. CHEN Q, Hu H, Jiao D, Yan J, et al
    miR-126-3p and miR-451a correlate with clinicopathological features of lung adenocarcinoma: The underlying molecular mechanisms.
    Oncol Rep. 2016;36:909-17.
    PubMed     Text format     Abstract available

  36. CHEN S, Jiang S, Hu F, Xu Y, et al
    Foxk2 inhibits non-small cell lung cancer epithelial-mesenchymal transition and proliferation through the repression of different key target genes.
    Oncol Rep. 2017 Feb 16. doi: 10.3892/or.2017.5461.
    PubMed     Text format     Abstract available

  37. CHOI YJ, Kim JH, Rho JK, Kim JS, et al
    AXL and MET receptor tyrosine kinases are essential for lung cancer metastasis.
    Oncol Rep. 2017 Mar 1. doi: 10.3892/or.2017.5482.
    PubMed     Text format     Abstract available

  38. MA J, Li J, Yao X, Lin S, et al
    FIGNL1 is overexpressed in small cell lung cancer patients and enhances NCI-H446 cell resistance to cisplatin and etoposide.
    Oncol Rep. 2017 Mar 1. doi: 10.3892/or.2017.5483.
    PubMed     Text format     Abstract available

  39. GUO CY, Yan C, Luo L, Goto S, et al
    Enhanced expression of PKM2 associates with the biological properties of cancer stem cells from A549 human lung cancer cells.
    Oncol Rep. 2017 Feb 10. doi: 10.3892/or.2017.5438.
    PubMed     Text format     Abstract available

  40. GUO Y, Sun W, Gong T, Chai Y, et al
    miR-30a radiosensitizes non-small cell lung cancer by targeting ATF1 that is involved in the phosphorylation of ATM.
    Oncol Rep. 2017 Feb 14. doi: 10.3892/or.2017.5448.
    PubMed     Text format     Abstract available

  41. CHEN YH, Zhou BY, Wu XJ, Xu JF, et al
    CCL22 and IL-37 inhibit the proliferation and epithelial-mesenchymal transition process of NSCLC A549 cells.
    Oncol Rep. 2016;36:2017-24.
    PubMed     Text format     Abstract available

  42. UTHAISAR K, Vaeteewoottacharn K, Seubwai W, Talabnin C, et al
    Establishment and characterization of a novel human cholangiocarcinoma cell line with high metastatic activity.
    Oncol Rep. 2016;36:1435-46.
    PubMed     Text format     Abstract available

  43. CHENG Q, Zhou L, Zhou J, Wan H, et al
    ACE2 overexpression inhibits acquired platinum resistance-induced tumor angiogenesis in NSCLC.
    Oncol Rep. 2016;36:1403-10.
    PubMed     Text format     Abstract available

  44. UGUEN A, Andrieu-Key S, Vergne F, Descourt R, et al
    ALK ambiguous-positive non-small cell lung cancers are tumors challenged by diagnostic and therapeutic issues.
    Oncol Rep. 2016;36:1427-34.
    PubMed     Text format     Abstract available

  45. DU H, Huang Y, Hou X, Yu X, et al
    DT-13 inhibits cancer cell migration by regulating NMIIA indirectly in the tumor microenvironment.
    Oncol Rep. 2016;36:721-8.
    PubMed     Text format     Abstract available

  46. FAN Z, Jiang H, Wang Z, Qu J, et al
    Atorvastatin partially inhibits the epithelial-mesenchymal transition in A549 cells induced by TGF-beta1 by attenuating the upregulation of SphK1.
    Oncol Rep. 2016;36:1016-22.
    PubMed     Text format     Abstract available

  47. WAN J, Wu W, Huang Y, Ge W, et al
    Incomplete radiofrequency ablation accelerates proliferation and angiogenesis of residual lung carcinomas via HSP70/HIF-1alpha.
    Oncol Rep. 2016;36:659-68.
    PubMed     Text format     Abstract available


    PLoS One

  48. SHEEHAN DF, Criss SD, Gazelle GS, Pandharipande PV, et al
    Evaluating lung cancer screening in China: Implications for eligibility criteria design from a microsimulation modeling approach.
    PLoS One. 2017;12:e0173119.
    PubMed     Text format     Abstract available

  49. ROSENBERGER A, Sohns M, Friedrichs S, Hung RJ, et al
    Gene-set meta-analysis of lung cancer identifies pathway related to systemic lupus erythematosus.
    PLoS One. 2017;12:e0173339.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: